Medicare spending on cancer drugs has skyrocketed in recent years, and Congress has severely limited the program's ability to do anything about it, says a report in the Feb. 7 issue of The New......
Germany-based pharma major Merck KGaA is targeting a five-fold increase in revenues from India over the next five years. The company, which bought biotech major Serono in 2007 to become a leading......
The German drug multinational, Merck KGaA, which received the Indian marketing approval for its head and neck cancer drug Erbitux last month,plans to conductfirst cancer vaccine trials in India.......
Could this finally be the end for Bristol-Myers Squibb Chief Executive Peter Dolan? A board meeting Tuesday, Sept. 12 could determine Dolan's fate. He is under fire because of a failed attempt to......
Before dot-coms, it was biotechnology that promised wild growth. And it still does. This month's Innovation Scorecard, an effort by Fast Company and Monitor Group to spot the most innovative......